Argenta reports Phase II COPD data

In a Phase II trial in 91 patients with chronic obstructive pulmonary disease (COPD), Argenta Discovery Ltd. (Harlow, U.K.) said its ADC4022 plus inhaled budesonide significantly improved lung functio...